The requirement of capreomycin, ethambutol and rifampicin in chronic pulmonary tuberculosis in Helsinki on the basis of resistance indications.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003523:Cycloserine; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000627:therapeutic use*; D005000:Ethionamide; D005387:Finland; D006801:Humans; D012293:Rifampin / Q000627:therapeutic use*; D013183:Sputum / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014756:Viomycin
D000900:Anti-Bacterial Agents; D004977:Ethambutol; D003523:Cycloserine; D005000:Ethionamide; D012293:Rifampin; D014756:Viomycin